TRETINOIN
Generic: TRETINOIN
Sun Pharmaceutical IndustriesManufacturer
TOPICALRoute
TRETINOINActive Substance
2019-01-22Original Approval
TRETINOIN is FDA application ANDA211645, sponsored by SUN PHARMA CANADA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2026-09-25
Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro PharFailed Impurities/Degradation Specifications
Class III2026-09-25
Tretinoin Cream UPS, 0.05%, 20g, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. bFailed Impurities/Degradation Specifications
Class III2026-09-25
Tretinoin Cream USP, 0.05%, 45g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, DisFailed Impurities/Degradation Specifications
Top Reported Reactions
1
OFF LABEL USE
877 reports
2
DRUG INEFFECTIVE
732 reports
3
PAIN
490 reports
4
PRODUCT USE IN UNAPPROVED INDICATION
483 reports
5
VOMITING
450 reports
6
PARAESTHESIA
373 reports
7
ABDOMINAL PAIN UPPER
369 reports
8
RASH
362 reports
9
NAUSEA
351 reports
10
DIARRHOEA
347 reports